DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— WeightWatchers - 2 Oprah Winfrey - 1 — - 1 Oprah giveth - 1 Oprah taketh - 1 maven - 1 Winfrey - 1 Axios - 1
Top related locs:
GLP WeightWatchers Ozempic
Top related orgs:
Business - 2 WW International - 1 Service - 1 SEC - 1 Guardian - 1 People Magazine - 1 MarketWatch - 1 Mayo Clinic - 1

Search resuls for: "— WeightWatchers"


2 mentions found


☆ Oprah has left WeightWatchers, sending stocks spiraling and spelling doom for the diet of our foremothers
  + stars: | 2024-02-29 | by ( Mia De Graaf | Rachel Hosie | ) www.businessinsider.com   time to read: +7 min
Oprah Winfrey will not seek reelection to the board of WW International, known as WeightWatchers. It was a surprising time to jump on board — WeightWatchers had been shedding users, and its stock price was dwindling. AdvertisementDespite not naming the brand, there was an immediate spike in demand for GLP-1 medications — the popular new class of weight-loss drugs. That same day, WW added a weight-loss drug arm to its business, acquiring Sequence, a service that provides weight-loss drugs. AdvertisementLong-term, WW needs to find a new identityOver time, WW will benefit from being a purveyor of hard-to-access weight-loss drugs.
Persons: Oprah Winfrey, —, Oprah giveth, Oprah taketh, maven, Winfrey, — WeightWatchers, Axios, Oprah, Forbes, Craig, Alex Fuhrman, Winfrey's, We're, Atkins Organizations: WW International, Service, SEC, Guardian, People Magazine, MarketWatch, Mayo Clinic, Business, Smithsonian's National Museum of, CNBC, Slate Locations: GLP, WeightWatchers
☆ 3 titans will fight to dominate the market for Wegovy in 2024
  + stars: | 2023-12-27 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +5 min
Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity. The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year. But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December. WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch. Ro launched its own program prescribing weight-loss drugs in January.
Persons: VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne Organizations: Business, Rock Health, Web, Getty, PitchBook Locations: Ozempic
0 next >>
Total: 2